Literature DB >> 5329367

A molecular concept of immune cytolysis.

H J Muller-Eberhard, U R Nilsson, A P Dalmasso, M J Polley, M A Calcott.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5329367

Source DB:  PubMed          Journal:  Arch Pathol        ISSN: 0363-0153


× No keyword cloud information.
  41 in total

1.  Presence of a dialysable fraction in normal bovine whey capable of killing several species of bovine mycoplasmas.

Authors:  C J Howard; J Brownlie; R N Gourlay; J Collins
Journal:  J Hyg (Lond)       Date:  1975-04

2.  Mechanism of complement activation by radiographic contrast media.

Authors:  C M Arroyave; E M Tan
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

3.  Immunofluorescence studies in reactional leprosy with relevance to treatment.

Authors:  W R Faber; D L Leiker; R H Cormane
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

4.  Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  Immunology       Date:  1967-07       Impact factor: 7.397

5.  Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.

Authors:  J B Ziegler; C A Alper; R S Rosen; P J Lachmann; L Sherington
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

6.  Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.

Authors:  B McLeod; T F Lint; P Baker; C Behrends; H Gewurz
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

7.  Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

8.  Activation of the alternative complement pathway in systemic lupus erythematosus.

Authors:  M R Wilson; C M Arroyave; R M Nakamura; J H Vaughan; E M Tan
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

9.  Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

10.  Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.

Authors:  M L Tamplin; S Specter; G E Rodrick; H Friedman
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.